Answers are grounded in this paper and cite their sources.
Maps peptide interactions in HLA-B51, suggesting new therapeutic approaches for Behçet's disease.
51:01 pathobiology and offers quantitative parameters to guide the design of therapeutic peptides or small molecules to modulate antigen presentation in Behçet's disease.
No takes yet. Share an insight, caveat, or question.
Yilmaz et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: